Investor Medtronic plc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Medtronic plc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-02-14 13G/A OBIO / Orchestra BioMed Holdings, Inc. 5,868,916 5,868,916
2024-02-14 13G/A OBIO / Orchestra BioMed Holdings, Inc. 4,999,423 5,868,916
2023-02-06 13G OBIO / Orchestra BioMed Holdings, Inc. 4,999,423
2022-01-13 13G NPCE / NeuroPace, Inc. 1,265,936 965,936
2021-05-03 13G NPCE / NeuroPace, Inc. 1,265,936
2019-02-01 13G ENTL / Entellus Medical, Inc. 956,926 0
2019-02-01 13G GID / GI DYNAMICS, INC. 0
2018-09-21 13D MZOR / Mazor Robotics Ltd. 4,208,790 4,208,790
2017-09-15 13G/A MZOR / Mazor Robotics Ltd. 1,958,684 4,208,790
2017-02-13 13G/A RVA / REVA Medical, Inc. 1,732,260
2017-02-13 13G/A RVA / 2,635,479 1,732,260
2017-02-13 13G/A RVALL / Reva Medical Inc
2016-08-22 13G MZOR / Mazor Robotics Ltd. 1,958,684
2016-02-16 13D/A NRGXQ / Neurologix, Inc. 2,036,171
2016-02-16 13G/A GID / GI DYNAMICS, INC. 782,308
2016-02-16 13G/A RVA / REVA Medical, Inc. 2,635,479
2016-02-16 13G/A RVA / 2,635,479
2016-02-16 13G ENTL / Entellus Medical, Inc. 956,926
2016-02-16 13G/A XENT / Intersect ENT Inc 460,276
2016-02-16 13G/A 00B5T6W85 / GI Dynamics Inc 782,308